This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: The General Hospital Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Ahhyun Stephanie Nam: Innovator in Optical Coherence Tomography
Introduction
Ahhyun Stephanie Nam is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of medical imaging, particularly in optical coherence tomography. His innovative work focuses on enhancing the measurement of blood flow parameters in blood vessels.
Latest Patents
Nam holds a patent for an invention titled "Using the dynamic forward scattering signal for optical coherence tomography based flow quantification." This patent describes an apparatus designed to measure a blood flow parameter in a blood vessel. The apparatus includes an interferometric data collection system that features a light source and a sensor connected to a controller. The controller is programmed to direct the light source toward the proximal side of a blood vessel, obtain interferometric data from tissue adjacent to the distal side, determine a signal modulation rate based on the data, and estimate a blood flow parameter based on this modulation rate. Nam's patent is a testament to his innovative approach in the medical field, with 1 patent to his name.
Career Highlights
Ahhyun Stephanie Nam is associated with The General Hospital Corporation, where he continues to advance his research and development efforts. His work is instrumental in improving diagnostic techniques and patient care through innovative imaging technologies.
Collaborations
Nam collaborates with Benjamin J. Vakoc, a fellow researcher, to further enhance the capabilities of their inventions and contribute to the medical imaging field.
Conclusion
Ahhyun Stephanie Nam's contributions to optical coherence tomography exemplify the impact of innovation in medical technology. His work not only advances scientific understanding but also has the potential to improve patient outcomes significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
